Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pharmacists

NewLink Genetics and Roche have teamed up to develop NewLink’s cancer immunothereapy in a $1 billion deal, Reuters reports. The NewLink inhibitor, NLG919, works to disrupt the process through which tumors elude a patient’s immune system....
According to The New York Times, the FDA has approved a pair of drugs that can slow the progression of idiopathic pulmonary fibrosis. Roche’s Esbriet and Boehringer Ingelheim’s Ofev do not cure the disease, but can slow the rate at which it...

The Fight Against Ebola

Human Trials for Ebola Vaccine Begin

According to an article published by CBS News, human trials for an Ebola vaccine are underway. After conducting successful trials in primates, GlaxoSmithKline is now testing its vaccine on healthy human volunteers in the US, UK, and Mali. Efficacy will...